Best Genomics Companies in Virginia, United States
The 34 best Genomics companies in Virginia, United States in 2026, ranked by funding and momentum. Funding, investors, founders, valuation, tech stack and live signals. Top: ZielBio.
Our analysis of 50 Genomics companies
$7.8b in tracked funding; 84% of the stack-profiled cohort runs cloud-native; funding activity peaked in 2025.
Ranked: Best Genomics companies in Virginia
| # | Company | Disclosed funding | Last round | Stage | Founder | Founded | Tech stack | Patents & IP focus | Recent signals |
|---|---|---|---|---|---|---|---|---|---|
| 1 | ZielBio Developer of targeted therapeutics for cancer | $26M | 85 mo ago | Series A | Kimberly A. Kelly CEO & CSO | 2010 | — | 7 patents Targeting plectin-1 with therapeutic antibodies for cancer diagnostics and therapy | — |
| 2 | Perthera Personalized molecular cancer profiling through genomics and proteomics | $18M | 48 mo ago | Series A | — | 2012 | — | 12 patents Patents concentrated in computing, sensing & instrumentation | — |
| 3 | Parabon NanoLabs Engineering DNA for next-generation nanotech, analytics, and forensics | $12M | 40 mo ago | Seed | — | 2005 | BootstrapAngularJSLodash+4 | 4 patents Nucleic acid nanostructure carriers for targeted pharmaceutical delivery | — |
| 4 | Gene Solutions Pioneering mitochondrial medicine, developing therapeutics for neurodegenerative and muscular diseases | $6M | 94 mo ago | Series A | David Patteson Co-Founder & Chairman | 2006 | — | — | — |
| 5 | Bode Technology Provider of portfolio DNA testing services | $5M | 33 mo ago | Acquired | Thomas Bode Founder | 1995 | WordPressMySQLPHP+19 | 47 patents Forensic sample collection devices with integrated reagents and controlled drying mechanisms | — |
| 6 | Aperiomics Provider of pathogen detection through genomics and bioinformatics | $4M | 70 mo ago | Deadpooled | — | 2013 | — | — | — |
| 7 | AMPEL Provider of bioinformatics platform for drug development | $3M | 46 mo ago | Funding Raised | Amrie Grammer Founder | 2013 | WordPressMySQLPHP+16 | — | — |
| 8 | ResourcePath Provider of services for pathologists and molecular biologists | $2M | 85 mo ago | Funding Raised | — | 2013 | — | — | — |
| 9 | GATACA AI-powered bioinformatics for virology, metagenomics, and oncology research | $2M | 175 mo ago | Funding Raised | — | 2004 | — | — | — |
| 10 | Techulon Developer of nucleic acid-based therapies for bacterial infections | $1M | 73 mo ago | Deadpooled | — | 2006 | — | 36 patents Patents concentrated in chemistry & materials | — |
| 11 | Ingenza Provider of bio-processes for manufacturing chemicals, biologics, pharmaceuticals, and biofuels | $970K | 29 mo ago | Seed | Ian Fotheringham CEO & MD | 2014 | WordPressPleskApple iCloud Mail+28 | — | — |
Top 12 Genomics companies in Virginia
#1
Acquired · Lorton, Virginia · founded 1995 · 224 employees$4.9Mraised▾
Provider of portfolio DNA testing services. The company offers DNA testing services for criminal cases, forensic parentage, and relationship testing. Also, offers DNA collection and investigative services.
- Jan 2024Grant (prize money)$659.3K
- Jan 2023Grant (prize money)$607.8K
- Jan 2022Grant (prize money)$437.4K
- Jan 2020Grant (prize money)$453.1K
#2
Seed · Reston, Virginia · founded 2005 · 17 employees$12.1Mraised▾
Engineering DNA for next-generation nanotech, analytics, and forensics. This is a biotechnology company integrating computation, chemistry, and genetic investigation to develop products and services for human health and public safety. They offer DNA nanotech solutions, including DNA design software and expert services, to revolutionize research. Their DNA forensics capabilities combine genetic genealogy, DNA phenotyping, and kinship analysis for advanced DNA analysis. They also provide DNA analytics software tools and diagnostic tests for deeply analyzing next-generation sequencing and SNP data for forensic and medical applications. The company's genetic genealogy services combine genetic analysis with historical and genealogical research to identify a DNA sample's related family members. They are involved in solving cold cases using advanced DNA technology and genetic genealogy, creating facial reconstructions from DNA, and identifying human remains.
- 2023Grant (prize money)$674.9K
- 2021Grant (prize money)$400K
- 2019Grant (prize money)$225.2K
- 2018Grant (prize money)$2.3M
#3
Seed · Midlothian, Virginia · founded 2014$969.6Kraised▾
Provider of bio-processes for manufacturing chemicals, biologics, pharmaceuticals, and biofuels. The company offers inABLE which is a proprietary set of tools that helps in recombinant DNA, protein synthesis, enzyme evolution, and biochemical pathway engineering for commercial applications.
- May 2024Seed—
- Dec 2016Grant (prize money)$52.7K
- Aug 2016Grant (prize money)$65.9K
- May 2015Grant (prize money)$851K
#4
Series A · Mclean, Virginia · founded 2012 · 13 employees$17.8Mraised▾
Personalized molecular cancer profiling through genomics and proteomics. Through the company’s PrecisOn process, Perthera will provide oncologists with a comprehensive understanding of the molecular architecture of their patients’ tumors. The multiple molecular analyses of each tumor will be integrated into Perthera’s Expert Oncologist system (also known as ExpO), an expert learning database that sources the most current clinical knowledge and research/drug information available, to facilitate analysis of multi-omic molecular profiles in context with the patient’s medical history.
- Sep 2022Series A$4.5M
- Jan 2019Series A$2.1M
- Dec 2017Series A$750K
- Jun 2016Series A$9.2M
#5
Funding Raised · Charlottesville, Virginia · founded 2013 · 33 employees$3Mraised▾
Provider of a bioinformatics platform for drug development. It offers clinicians and biomedical companies with bioinformatics data and helps in developing personalized drugs.
- Dec 2022Conventional Debt$1.1M
- Jun 2021Conventional Debt$350K
- Feb 2021Conventional Debt$500K
- Jan 2021Conventional Debt$1M
#6
Series A · Charlottesville, Virginia · founded 2010 · 10 employees$25.9Mraised▾
Developer of targeted therapeutics for cancer. The company uses ZielFind, a target discovery platform to discover new targets. The company's lead molecules, ZB131 fMAb & ZB220 ADC are being developed to target cell surface cytolinker proteins, Plectin-1 as anticancer drugs. The company is also discovering novel cell targets for cardiology, neurology & metabolic diseases with other partners.
- Sep 2019Series A$25.1M
- Jun 2017Seed$755K
- Jul 2015Seed$450K
- Aug 2012Grant (prize money)$301.3K
#7
Deadpooled · Ashburn, Virginia · founded 2013 · 10 employees$4.4Mraised▾
Provider of pathogen detection through genomics and bioinformatics. The company uses a sequencing and genomic analysis approach, for pathogen discovery, diagnosing difficult cases of unknown etiology, pathogen surveillance, and monitoring of natural animal populations, as well as routine pathogen detection.
- Dec 2020Series A$1.2M
- Nov 2020Conventional Debt$300K
- Oct 2020Series A$150K
- Aug 2019Series A$1.8M
#8
Series A · Charlottesville, Virginia · founded 2006 · 4 employees$6.3Mraised▾
Pioneering mitochondrial medicine, developing therapeutics for neurodegenerative and muscular diseases. This company is focused on transforming the treatment of mitochondrial-based neurodegenerative and muscular diseases by targeting mutations in mitochondrial DNA. Through innovative research, they've developed a novel chemical synthetic pathway for designing Mito-DNA target imprecision therapeutics. They empower pharmaceutical innovation with validated mitochondrial targets, high-fidelity functional assays, and novel small molecules. With scientific leadership and integrated teams, they are unlocking the next generation of mitochondrial medicine to treat smarter and deliver lasting impacts for patients facing challenging diseases. This is a B2B model, offering research and development services, and novel molecules for pharmaceutical innovation.
- Dec 2018Series A$5.3M
- Aug 2017Seed$65K
- Oct 2015Seed$639.8K
- Feb 2013Seed$298K
#9
Deadpooled · Blacksburg, Virginia · founded 2006 · 4 employees$1.3Mraised▾
Developer of nucleic acid-based therapies for bacterial infections. Its solutions defeat bacteria at the genomic level by using its key technology, Peptide-Peptide Nucleic Acid (PPNAs). The company's drugs are using its RANT platform, which can reveal DNA sequences in genes.
- Aug 2020Seed—
- Jul 2019Conventional Debt$395K
- Oct 2017Seed$200K
- May 2013Grant (prize money)$1.9M
#10
Funding Raised · Sterling, Virginia · founded 2013$1.7Mraised▾
Provider of services for pathologists and molecular biologists. It offers DICER1 genetic tests and research, RNA-seq gene expression and analysis, cancer mutation analysis. and others. It is CLIA certified and CAP-accredited.
- Sep 2019Grant (prize money)$224.7K
- May 2018Grant (prize money)$1.5M
#11
Funding Raised · Newport News, Virginia · founded 2004$1.6Mraised▾
AI-powered bioinformatics for virology, metagenomics, and oncology research. They develop pathogen-specific software solutions, leveraging deep machine learning and proprietary algorithms. Their GAT/ML pipeline enables de novo assembly, biomarker identification, and haplotype reconstruction for viruses like HBV and HIV. The software is designed for academic scientists, antiviral drug developers, and clinical scientists using NGS data. It offers capabilities in functional trait analysis, dynamic databases, and integration of workflows. The company aims to streamline discovery, improve data management, and facilitate research in genomics and disease analysis. They provide custom analysis tools, editing/writing services, and study design consultation. This is a B2B, SaaS, software solution.
- Mar 2012Grant (prize money)—
- Mar 2012Grant (prize money)$1.4M
- Jul 2009Grant (prize money)—
- Jun 2009Grant (prize money)$183.9K
#12
Seed · Richmond, Virginia · founded 2013—raised▾
Provider of diagnostic tests to identify risk levels of patients. The company has developed the Brain Injury Recovery Test (BIRT), which is an easy-to-administer genetic test performed on a saliva sample to identify whether a person has a higher than normal risk of long-term effects on the brain after a concussion.
- Aug 2014Seed—
Funding & investor landscape
Notable founders
Market landscape — 10 sub-themes by coverage
Share of Genomics coverage by sub-theme.
Regulatory-risk over time rising
Funding & growth over time
funding rising · growth rising
How research on Bioinformatics in Virginia is moving
A read on the academic research around Bioinformatics in Virginia — which themes are gaining ground, the institutions and researchers driving them, and how the tone is shifting. Based on 164 papers.
- University of Virginia68
- Virginia Commonwealth University34
- Virginia Tech29
- West Virginia University7
- University of Virginia Health System7
- Gene1→14
- Genome1→7
- Transcriptome1→6
- Cancer1→3
- Disease1→4
Common questions
Rohit lives in the feed. He covers what's moving right now — the funding rounds, launches and shifts breaking across the trade press — and ties them back to where the sector is heading.